8-hydroxy-2--deoxyguanosine and Seizures--Febrile

8-hydroxy-2--deoxyguanosine has been researched along with Seizures--Febrile* in 1 studies

Other Studies

1 other study(ies) available for 8-hydroxy-2--deoxyguanosine and Seizures--Febrile

ArticleYear
Changes in cerebrospinal fluid biomarkers in human herpesvirus-6-associated acute encephalopathy/febrile seizures.
    Mediators of inflammation, 2014, Volume: 2014

    To determine the involvement of oxidative stress in the pathogenesis of acute encephalopathy associated with human herpesvirus-6 (HHV-6) infection, we measured the levels of oxidative stress markers 8-hydroxy-2'-deoxyguanosine (8-OHdG) and hexanoyl-lysine adduct (HEL), tau protein, and cytokines in cerebrospinal fluid (CSF) obtained from patients with HHV-6-associated acute encephalopathy (HHV-6 encephalopathy) (n = 16) and complex febrile seizures associated with HHV-6 (HHV-6 complex FS) (n = 10). We also examined changes in CSF-8OHdG and CSF-HEL levels in patients with HHV-6 encephalopathy before and after treatment with edaravone, a free radical scavenger. CSF-8-OHdG levels in HHV-6 encephalopathy and HHV-6 complex FS were significantly higher than in control subjects. In contrast, CSF-HEL levels showed no significant difference between groups. The levels of total tau protein in HHV-6 encephalopathy were significantly higher than in control subjects. In six patients with HHV-6 infection (5 encephalopathy and 1 febrile seizure), the CSF-8-OHdG levels of five patients decreased after edaravone treatment. Our results suggest that oxidative DNA damage is involved in acute encephalopathy associated with HHV-6 infection.

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adolescent; Antipyrine; Biomarkers; Child; Deoxyguanosine; DNA Damage; Edaravone; Female; Herpesvirus 6, Human; Humans; Male; Roseolovirus Infections; Seizures, Febrile; Young Adult

2014